These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9322345)

  • 21. Clinical and economic considerations of empirical antibacterial therapy of febrile neutropenia in cancer.
    Dranitsaris G
    Pharmacoeconomics; 1999 Oct; 16(4):343-53. PubMed ID: 10623363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empiric therapy for febrile neutropenia: what are the choices?
    Aoun M
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):507-15. PubMed ID: 17547514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once-daily aminoglycosides in patients with neutropenic fever.
    Aiken SK; Wetzstein GA
    Cancer Control; 2002; 9(5):426-31. PubMed ID: 12410181
    [No Abstract]   [Full Text] [Related]  

  • 24. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients.
    Bennett JE; Powers J; Walsh T; Viscoli C; de Pauw B; Dismukes W; Galgiani J; Glauser M; Herbrecht R; Kauffman C; Lee J; Pappas P; Rex J; Verweij P
    Clin Infect Dis; 2003 Apr; 36(Suppl 3):S117-22. PubMed ID: 12679895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combating infections in neutropenic patients.
    Pizzo PA
    Hosp Pract (Off Ed); 1989 Jul; 24(7):93-100, 103-4, 107-10. PubMed ID: 2501330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Amikacin in the treatment of febrile complications occurring during the neutropenic phase of acute hemopathies].
    Fiere D; Vu Van H; Espinouse D; Reynaud J; Coiffier B; Felman P; Vialard L
    Nouv Presse Med; 1979 Oct; 8(42):3469-71. PubMed ID: 295114
    [No Abstract]   [Full Text] [Related]  

  • 27. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.
    Viscoli C; Bruzzi P; Glauser M
    Eur J Cancer; 1995 Nov; 31A(12):2013-22. PubMed ID: 8562158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.
    Ichikawa M; Suzuki D; Ohshima J; Cho Y; Kaneda M; Iguchi A; Ariga T
    Pediatr Blood Cancer; 2011 Dec; 57(7):1159-62. PubMed ID: 21438131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation].
    Zikesoá E; Hnátková M; Vacková B; Jedlicková A; Klener P; Trnený M
    Cas Lek Cesk; 2006; 145(5):383-6, 388-9. PubMed ID: 16755776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infection in the cancer patient. The management of neutropenic fever].
    Provencio M; López-Vega JM; Bonilla F; España P
    An Med Interna; 1993 Mar; 10(3):143-6. PubMed ID: 8485286
    [No Abstract]   [Full Text] [Related]  

  • 32. Outpatient management of febrile neutropenia in children with cancer.
    Holdsworth M; Hanrahan J; Albanese B; Frost J
    Paediatr Drugs; 2003; 5(7):443-55. PubMed ID: 12837117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of febrile neutropenia].
    Urabe A
    Rinsho Ketsueki; 2009 Feb; 50(2):69-72. PubMed ID: 19265296
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
    Ramphal R; Gucalp R; Rotstein C; Cimino M; Oblon D
    Am J Med; 1996 Jun; 100(6A):83S-89S. PubMed ID: 8678102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fever and neutropenia in children with malignant disease.
    Roguin A; Kasis I; Ben-Arush MW; Sharon R; Berant M
    Pediatr Hematol Oncol; 1996; 13(6):503-10. PubMed ID: 8940733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Procalcitonin adds to diagnosis, but does not reduce initial antibiotics in febrile neutropenic children.
    Lodahl D; Schrøder H
    Dan Med Bull; 2011 Mar; 58(3):A4233. PubMed ID: 21371399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].
    Fouyssac F; Salmon A; Mansuy L; Schmitt C; Bordigoni P; Chastagner P
    Med Mal Infect; 2005 Jun; 35(6):357-62. PubMed ID: 15982848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
    Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
    J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration.
    Hughes WT; Pizzo PA; Wade JC; Armstrong D; Webb CD; Young LS
    Clin Infect Dis; 1992 Nov; 15 Suppl 1():S206-15. PubMed ID: 1477232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.
    Glasmacher A; von Lilienfeld-Toal M; Schulte S; Hahn C; Schmidt-Wolf IG; Prentice A
    Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():17-23. PubMed ID: 16138815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.